Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of GSK3196165 in inflammatory hand osteoarthritis
2015-003089-96Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hand osteoarthritis comparing GSK3196165 with Placebo (2 arms). Primary endpoint: Change from baseline in 24-hour average hand pain intensity. Started Oct 2015; status: completed.
02
Drugs
otilimab
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on 2015-003089-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003089-96.